2023-02-02 2023-02-02 , online online, 1,490 € zzgl. MwSt. Dr. Thomas Ecker https://www.forum-institut.de/seminar/23042201-market-access-pricing-in-europe/referenten/23/23_04/23042201-market-access-pricing-in-europe_ecker-thomas.jpg Market Access & Pricing in Europe

Online seminar about Market Access & Pricing in Europe

Topics
  • Reference Pricing in Europe
  • Payer-Archetyping
  • Market Access and Pricing in France, Italy, Spain, Germany and the UK
  • Specialties with regard to ATMPs/Gentherapeutics
  • HTA process and the role of RWE in the HTA context


Who should attend
This online seminar is aimed at specialists and executives in the healthcare industry who are involved in market access and pricing in Europe.
Aims and objectives
Market access and pricing for drugs is complex and requires careful preparation for launch. Knowledge of the underlying health systems and the different, mutually influencing pricing systems in Europe is essential for it.

In our online seminar you will receive the most important information for successful market access in the EU4 countries and in the UK.

27th April 2023: Market Access and Pricing in France, Germany and the UK

28th April 2023: Market Access and Pricing in Spain and in Italy
Your benefit

By attending the seminar...

  • you know about the most important differences and similarities with regard to market access in Europe
  • you have insights in key trends in pricing & market access in Europe
  • you know how to avoid pitfalls in regard to price-referencing
  • you will get practical tips for your work in Market Access & Pricing
  • you will benefit from the experience of our experts

Market Access & Pricing in EU5

Market Access & Pricing in Europe

Online seminar on Payer Contracts, HTA process and tender management

Benefits
  • Insights in Market Access & Pricing in EU4 countries + UK
  • Experts with local know-how
  • Sufficient time for your questions
  • Also possible as in-house
  • We are following the IMI quality criteria

Webcode 23042201

Jetzt buchen

JETZT Buchen

Referenten


Alles auf einen Blick

Termin

27-28/04/2023

27-28/04/2023

Zeitraum

27th April 2023: 9:00 am - 3:00 pm28...

27th April 2023: 9:00 am - 3:00 pm
28th April 2023: 9:00 am - 1:00 pm
Veranstaltungsort

online

online

Gebühr
Your contact

Leila Grupp
Conference Manager

+49 6221 500-695
l.grupp@forum-institut.de

Details

Online seminar about Market Access & Pricing in Europe

Topics
  • Reference Pricing in Europe
  • Payer-Archetyping
  • Market Access and Pricing in France, Italy, Spain, Germany and the UK
  • Specialties with regard to ATMPs/Gentherapeutics
  • HTA process and the role of RWE in the HTA context


Who should attend
This online seminar is aimed at specialists and executives in the healthcare industry who are involved in market access and pricing in Europe.
Aims and objectives

Market access and pricing for drugs is complex and requires careful preparation for launch. Knowledge of the underlying health systems and the different, mutually influencing pricing systems in Europe is essential for it.

In our online seminar you will receive the most important information for successful market access in the EU4 countries and in the UK.

27th April 2023: Market Access and Pricing in France, Germany and the UK

28th April 2023: Market Access and Pricing in Spain and in Italy

Your benefit

By attending the seminar...

  • you know about the most important differences and similarities with regard to market access in Europe
  • you have insights in key trends in pricing & market access in Europe
  • you know how to avoid pitfalls in regard to price-referencing
  • you will get practical tips for your work in Market Access & Pricing
  • you will benefit from the experience of our experts

Detailed programme

27th April 2023: 9:00 am - 3:00 pm
28th April 2023: 9:00 am - 1:00 pm

09:00 Introduction


09:10

Graham Foxon

Market Access & Pricing in France
  • Stakeholder in France
  • HTA process and the role of RWE in the HTA context
  • Pricing negociation with CEPS; Value based pricing approaches?
  • Managed Access Entry Agreements & Patient Access Schemes; role of ATU
  • Specialties with regard to ATMPs/Gentherapeutics
  • Price, volume & revenues forecasting

10:45 break


11:00

Thomas Ecker

Market Access & Pricing in Germany
  • The AMNOG process 2023 - role of RWE?
  • Challenge AbDe
  • Managed Access Entry Agreements & Patient Access Schemes - what is possible
  • Price, volume & revenues: new requirements!
  • Recent legal changes for price negotiations
  • Value based pricing approaches
  • Market Access and pricing for medical apps

12:30 Lunch break


13:15

Graham Foxon

Market Access & Pricing in the UK
  • Stakeholder & Stakeholder mapping post Brexit
  • Managed Access Entry Agreements & Patient Access Schemes
  • Role of RWE in the HTA context
  • Specialties with regard to ATMPs/Gentherapeutics/Orphan drugs
  • Value based pricing approaches
  • Price, volume & revenues

15:00 End of day 1


09:00 Start of day 2


09:01

Marta Taboada Rodríguez

Market Access & Pricing in Spain
  • Stakeholder in Spain
  • HTA process and the role of RWE
  • Negociation with SGCMPS
  • Patient Access Schemes
  • Specialties with regard to ATMPs/Gentherapeutics/Orphan drugs
  • Price, volume & revenues forecasting

10:45 break


11:00

Mariangela Prada

Market Access & Pricing in Italy
  • Stakeholder in Italy
  • Managed Access Entry Agreements & Patient Access Schemes
  • Role of RWE in the HTA context
  • Specialties with regard to ATMPs/Gentherapeutics/Orphan drugs
  • Value based pricing approaches
  • Price, volume & revenues

13:00 End of seminar


This distinguishes our events

Overall score of all evaluations in 2022

Five stars on Trustpilot = Excellent

Recommendations

Real World Data für die Klinische Forschung erstellen und nutzen

Auf diesem Online Seminar erfahren Sie, worauf es ankommt, wenn Sie Real World Data gewinnen und digital generierte Date...

28.03.2023, Online
Details

Erfolgreiches Marketing für DiGA

Die Entwicklung Ihrer DiGA ist abgeschlossen und im nächsten Schritt geht es um die Vermarktung des Produkts? In diesem ...

27.04.2023, Online
Details

Pharmacovigilance Inspection Readiness

Our online course will provide insights into the current (remote) pharmacovigilance inspection strategy in Europe. Learn...

24.04.2023, Online
Details

RMP and PSUR in life-cycle management: An art, not a miracle

Tips & tricks for managing periodic reports and risk management plans post marketing authorisation. Furthermore insights...

22.03.2023, Online
Details

Online-Content für Ärzte

Ihr Seminar für eine gelungene Onlinekommunikation mit Ihren Ärzten.

16.03.2023, Online
Details

Go forward

In-house seminars

Our programmes are also available for in-house training. Just contact us!

Details
Inhouse
Whitepaper "Generic Drugs: Market Access and Pricing in Europe"

Get a first insight into generic market access and pricing in Europe.

Details
Whitepaper
Quality guaranteed!

Your feedback produced as result of 1.8 in 2022. Thank you!

Details
More on our quality criteria